Response to Capmatinib in a MET Fusion-Positive Cholangiocarcinoma

Turpin, A; Descarpentries, C; Grégoire, V; Farchi, O; Cortot, AB; Jamme, P

Jamme, P (通讯作者),CHU Lille, Dept Dermatol, Hop Claude Huriez, Rue Michel Polonowski, F-59000 Lille, France.

ONCOLOGIST, 2023; 28 (1): 80

Abstract

Cholangiocarcinoma is the second most common liver cancer after hepatocellular carcinoma. In case of metastatic or unresectable disease, the recommend......

Full Text Link